This is a prospective cohort observational registry study that will include data on all patients who are treated at MHS facilities for COVID-19.
This is a prospective cohort observational registry study that will include data on all
patients who are treated at MHS facilities for COVID-19. Data including, but not limited to
demographics, comorbidities, medications, treatment, and clinical outcomes will be collected
from February 2020 to December 2025. Subjects will undergo no additional tests or procedures
as part of this registry study. All patient data will be obtained from the patient's
electronic health records (EHR) of the hospital or clinic in a retrospective manner. The
process for gathering the data will not influence treatment decisions. There will be no
direct patient contact associated with inclusion in this registry study.
Other: Treatment for COVID-19
Patients treated for COVID-19
Inclusion Criteria:
- Patient tested positive for COVID-19 (SARS-CoV-2)
- Patient sought care for COVID-19 at a MHS facility
- Aged 18 years or older
Exclusion Criteria:
- Patient that do not have COVID-19
- Non-confirmed COVID-19 patients
- Aged 17 years or younger
Clinical Research Institute Methodist Health System
Dallas, Texas, United States
Investigator: Crystee Cooper, DHEd
Contact: 214-941-1285
CrysteeCooper@mhd.com
Crystee Cooper, DHEd
214-947-1285
clinicalresearch@mhd.com
Zaid Haddadin, MS
214-947-4604
clinicalresearch@mhd.com
Crystee Cooper, DHEd, Principal Investigator
Methodist Health System